SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-024881
Filing Date
2024-06-24
Accepted
2024-06-24 08:34:40
Documents
18
Period of Report
2024-06-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43846
2 ex99-1.htm EX-99.1 18354
3 ex99-1_001.jpg GRAPHIC 5879
4 ex99-1_002.jpg GRAPHIC 43167
5 ex99-2_003.jpg GRAPHIC 160797
  Complete submission text file 0001493152-24-024881.txt   581257

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bfri-20240624.xsd EX-101.SCH 3967
7 XBRL DEFINITION FILE bfri-20240624_def.xml EX-101.DEF 26984
8 XBRL LABEL FILE bfri-20240624_lab.xml EX-101.LAB 37210
9 XBRL PRESENTATION FILE bfri-20240624_pre.xml EX-101.PRE 25604
22 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6684
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40943 | Film No.: 241062189
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)